Valuation: Amedica Corporation

Market Cap 8.21M 7.17M 6.59M 6.15M 11.66M 781M 11.83M 79.15M 30.77M 384M 30.8M 30.14M 1.32B P/E 2026 *
-0.89x
P/E 2027 * -1.33x
Enterprise Value 8.21M 7.17M 6.59M 6.15M 11.66M 781M 11.83M 79.15M 30.77M 384M 30.8M 30.14M 1.32B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 1.56x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2007-11-30
President - 2026-03-15
Director of Finance/CFO 41 2025-09-03
Director TitleAgeSince
Director/Board Member 63 2007-11-30
Director/Board Member 63 2025-04-02
Director/Board Member 72 2012-11-04
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%-1.85%-17.39%+9.58% 125B
+0.04%-1.01%+1.39%-6.08% 12.77B
+7.83%+2.71%+43.32%+112.86% 8.71B
+2.29%+7.17%-46.92%-72.29% 4.07B
+4.16%+8.39%+25.37%+43.89% 2.73B
+2.53%+23.07%-7.66%-13.04% 1.89B
+3.55%+8.85%-0.99%-23.29% 1.67B
-5.25%-5.89%+179.33%+133.76% 1.46B
Average +2.42%+1.23%+22.06%+23.17% 19.81B
Weighted average by Cap. +3.90%+2.90%-10.46%+13.01%

Financials

2026 *2027 *
Net sales 2.3M 2.01M 1.85M 1.72M 3.27M 219M 3.32M 22.22M 8.64M 108M 8.65M 8.46M 372M 5.27M 4.6M 4.23M 3.94M 7.48M 502M 7.59M 50.8M 19.75M 247M 19.77M 19.35M 850M
Net income -12.38M -10.82M -9.94M -9.27M -17.58M -1.18B -17.85M -119M -46.41M -579M -46.46M -45.47M -2B -11.38M -9.95M -9.14M -8.52M -16.16M -1.08B -16.4M -110M -42.66M -532M -42.7M -41.79M -1.83B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-